Geode Capital Management
WINT

Geode Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Geode Capital Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-54,795
Closed -$62K – 4171
2017
Q1 		$62K Buy
54,795
+144
+0.3% +$187 ﹤0.01% 3912
2016
Q4 		$67K Buy
54,651
+96
+0.2% +$177 ﹤0.01% 3869
2016
Q3 		$140K Buy
54,555
+24
+0% +$52 ﹤0.01% 3713
2016
Q2 		$105K Hold
54,531
– – ﹤0.01% 3793
2016
Q1 		$89 Sell
54,531
-25
-0% -$54 ﹤0.01% 3860
2015
Q4 		$163K Buy
54,556
+48
+0.1% +$197 ﹤0.01% 3752
2015
Q3 		$228K Buy
54,508
+21,907
+67% +$145K ﹤0.01% 3633
2015
Q2 		$310K Buy
32,601
+25
+0.1% +$351 ﹤0.01% 3415
2015
Q1 		$542K Buy
32,576
+73
+0.2% +$1.44K ﹤0.01% 3165
2014
Q4 		$527K Buy
32,503
+73
+0.2% +$1.6K ﹤0.01% 3166
2014
Q3 		$835K Buy
32,430
+1,099
+4% +$26.5K ﹤0.01% 2887
2014
Q2 		$780K Buy
31,331
+3,224
+11% +$82.4K ﹤0.01% 2942
2014
Q1 		$846K Buy
28,107
+7,531
+37% +$253K ﹤0.01% 2888
2013
Q4 		$648K Buy
20,576
+7,474
+57% +$234K ﹤0.01% 2955
2013
Q3 		$360K Buy
13,102
+2
+0% +$48 ﹤0.01% 3092
2013
Q2 		$279K Buy
+13,100
New +$323K ﹤0.01% 3117

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Geode Capital Management's WINT Position: Q2 2017 in Review

Geode Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 54,795 shares — an estimated $62K sold.

Geode Capital Management first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $846K in Q1 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Geode Capital Management reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Geode Capital Management sold 54,795 Windtree Therapeutics Inc shares in Q2 2017, an estimated $62K.
  • Geode Capital Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Geode Capital Management's Windtree Therapeutics Inc position peaked at $846K in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.